<?xml version="1.0" encoding="UTF-8"?>
<p id="Par26">In support of a dysregulated B cell response to SARS-CoV-2 infection, analyses of circulating B cells showed expansion of oligoclonal plasmablasts and reduced memory B cell frequencies in patients with severe COVID-19 compared with responses in patients with mild disease or healthy individuals
 <sup>
  <xref ref-type="bibr" rid="CR42">42</xref>,
  <xref ref-type="bibr" rid="CR102">102</xref>,
  <xref ref-type="bibr" rid="CR103">103</xref>
 </sup>. The antibody sequences of the largest B cell clones detected in patients with severe COVID-19 were variable in terms of somatic hypermutation levels and 
 <xref rid="Glos8" ref-type="list">VH gene</xref> usage, suggesting a polyclonal B cell response
 <sup>
  <xref ref-type="bibr" rid="CR102">102</xref>
 </sup>, possibly arising via an extra-follicular pathway, as reported in a preprint study
 <sup>
  <xref ref-type="bibr" rid="CR104">104</xref>
 </sup>. Plasmablast levels in patients with COVID-19 did not correlate with antibody levels against the spike protein, suggesting that these cells generated antibodies against antigens other than the spike protein or generated antibodies with low specificity and affinity.
</p>
